ArticleCancer research2024

Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.

Margaret R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.